• 22ND NOVEMBER 2022

    November 2022 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (22/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Alendronic acid 70mg tablets 4 £5.36 Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amorolfine 5% medicated nail lacquer 5 £7.34 Aripiprazole

    Read more
    • 21ST NOVEMBER 2022

    Help improve the Electronic Prescription Service

    NHS Digital is asking community pharmacy team members to share their experience of using the Electronic Prescription Service (EPS) by volunteering to take part with a short EPS interview. Such user feedback is essential to informing the future development of the system ahead of the planned launch of the next generation of EPS. PSNC and

    Read more
    • 21ST NOVEMBER 2022

    MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited)

    Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) Drug alert number: EL (22)A/48 Date issued: 21 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Hyoscine Butylbromide 20 mg film-coated tablets, PL 20117/0349 Batch Number Expiry Date Pack

    Read more
    • 18TH NOVEMBER 2022

    November 2022 Price Concessions 1st Update

    The Department of Health and Social Care (DHSC) has today (18/11/2022) granted the following initial list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.69 Amoxicillin 250mg/5ml oral suspension sugar free 100 £2.69 Benzydamine 0.15% mouthwash sugar free 300 £4.65 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol

    Read more
    • 17TH NOVEMBER 2022

    Autumn Statement: PSNC calls for investment in pharmacies

    The Chancellor of the Exchequer, Jeremy Hunt, has today (17th November) given his Autumn Statement, setting out Government spending plans. The Statement promises that the NHS budget will be increased in each of the next two years by £3.3bn, going some way towards meeting the request of NHS CEO Amanda Pritchard. But the Chancellor made

    Read more
    • 17TH NOVEMBER 2022

    PSNC hosts well attended parliamentary event

    On Tuesday 15th November PSNC hosted a parliamentary drop-in event for MPs and peers. The event lasted for two hours, during which MPs had the opportunity to drop-in and have their blood pressure measured by a pharmacists with experience of working on the front-line and were briefed on the urgent need for action to address

    Read more
    • 16TH NOVEMBER 2022

    Two SSPs issued for Estraderm® MX 50mcg and 75mcg patches

    In response to a significant ongoing disruption to the supply of Estraderm MX® 50mcg and 75mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 15 November 2022, SSP037 and SSP038 provides for the following: SSP037 – for every Estraderm MX® 50mcg  patch originally prescribed, one

    Read more
    • 16TH NOVEMBER 2022

    MHRA – Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

    Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (22)A/47 Date issued: 16 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 300 mg prolonged-release tablets, PL 01883/0363 Batch Number Expiry

    Read more
    • 16TH NOVEMBER 2022

    Two weeks left to complete mandatory workforce survey

    Community pharmacy contractors are reminded of the mandatory requirement to complete the 2022 Community Pharmacy Workforce Survey, managed by Health Education England (HEE), by 30th November 2022. Completion of the survey is a mandatory requirement for all contractors. The NHS Business Services Authority (NHSBSA) sent an email to contractors on 6th October 2022 containing a link to the

    Read more
    • 15TH NOVEMBER 2022

    Reminder: Packaged dose endorsement on prescriptions for methadone oral liquid

    When dispensing FP10MDA or FP10 prescriptions for methadone oral liquid, pharmacy contractors can claim packaged dose fees of £0.55 for each individual dose supplied in advance in daily dose containers. The number of packaged dose (‘PD’) fees to claim for is calculated as the total number of separately packaged doses given minus the number of

    Read more